- Home
- BRTX vs MTNB Comparison
BRTX vs MTNB Comparison
Compare BRTX & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- MTNB
- Stock Information
- Founded
- BRTX 1997
- MTNB 2013
- Country
- BRTX United States
- MTNB United States
- Employees
- BRTX N/A
- MTNB N/A
- Industry
- BRTX Managed Health Care
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- BRTX Health Care
- MTNB Health Care
- Exchange
- BRTX Nasdaq
- MTNB Nasdaq
- Market Cap
- BRTX 12.8M
- MTNB 10.8M
- IPO Year
- BRTX N/A
- MTNB N/A
- Fundamental
- Price
- BRTX $1.50
- MTNB $1.34
- Analyst Decision
- BRTX
- MTNB Hold
- Analyst Count
- BRTX 0
- MTNB 1
- Target Price
- BRTX N/A
- MTNB N/A
- AVG Volume (30 Days)
- BRTX 304.1K
- MTNB 36.7K
- Earning Date
- BRTX 11-13-2025
- MTNB 11-05-2025
- Dividend Yield
- BRTX N/A
- MTNB N/A
- EPS Growth
- BRTX N/A
- MTNB N/A
- EPS
- BRTX N/A
- MTNB N/A
- Revenue
- BRTX $605,200.00
- MTNB N/A
- Revenue This Year
- BRTX $232.67
- MTNB N/A
- Revenue Next Year
- BRTX $52.92
- MTNB N/A
- P/E Ratio
- BRTX N/A
- MTNB N/A
- Revenue Growth
- BRTX 247.62
- MTNB N/A
- 52 Week Low
- BRTX $1.19
- MTNB $0.47
- 52 Week High
- BRTX $2.55
- MTNB $3.09
- Technical
- Relative Strength Index (RSI)
- BRTX 42.27
- MTNB 32.07
- Support Level
- BRTX $1.49
- MTNB $1.33
- Resistance Level
- BRTX $1.70
- MTNB $1.42
- Average True Range (ATR)
- BRTX 0.09
- MTNB 0.12
- MACD
- BRTX -0.01
- MTNB -0.04
- Stochastic Oscillator
- BRTX 14.81
- MTNB 6.35
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.